These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 34752313)

  • 21. Predictors of recurrence of multidrug-resistant and extensively drug-resistant tuberculosis.
    Blöndal K; Viiklepp P; Guðmundsson LJ; Altraja A
    Int J Tuberc Lung Dis; 2012 Sep; 16(9):1228-33. PubMed ID: 22748131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.
    Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y
    Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multidrug- and Extensively Drug-Resistant Mycobacterium tuberculosis Beijing Clades, Ukraine, 2015.
    Merker M; Nikolaevskaya E; Kohl TA; Molina-Moya B; Pavlovska O; Brännberg P; Dudnyk A; Stokich V; Barilar I; Marynova I; Filipova T; Prat C; Sjöstedt A; Dominguez J; Rzhepishevska O; Niemann S
    Emerg Infect Dis; 2020 Mar; 26(3):481-490. PubMed ID: 32091369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mycobacterial interspersed repetitive unit typing and mutational profile for multidrug-resistant and extensively drug-resistant tuberculosis surveillance in Portugal: a 3-year period overview.
    Silva C; Perdigão J; Jordão L; Portugal I
    Int J Antimicrob Agents; 2014 Dec; 44(6):546-51. PubMed ID: 25270633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Isoniazid mono-resistant tuberculosis: Time to take it seriously.
    Garg K; Saini V; Dhillon R; Agarwal P
    Indian J Tuberc; 2019 Apr; 66(2):247-252. PubMed ID: 31151492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A critical review of risk factors influencing the prevalence of extensive drug-resistant tuberculosis in India.
    Khan AH; Nagoba BS; Shiromwar SS
    Int J Mycobacteriol; 2023; 12(4):372-379. PubMed ID: 38149530
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for extensive drug resistance in multidrug-resistant tuberculosis cases: a case-case study.
    Guglielmetti L; Veziris N; Aubry A; Brossier F; Bernard C; Sougakoff W; Jarlier V; Robert J
    Int J Tuberc Lung Dis; 2018 Jan; 22(1):54-59. PubMed ID: 29297426
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Household contact investigation of multidrug-resistant and extensively drug-resistant tuberculosis in a high HIV prevalence setting.
    Vella V; Racalbuto V; Guerra R; Marra C; Moll A; Mhlanga Z; Maluleke M; Mhlope H; Margot B; Friedland G; Shah NS; Gandhi NR
    Int J Tuberc Lung Dis; 2011 Sep; 15(9):1170-5, i. PubMed ID: 21943840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidrug-resistant and extensively drug resistant tuberculosis in Kashmir, India.
    Datta BS; Hassan G; Kadri SM; Qureshi W; Kamili MA; Singh H; Manzoor A; Wani MA; Shamas-u-Din ; Thakur N
    J Infect Dev Ctries; 2009 Nov; 4(1):19-23. PubMed ID: 20130374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Epidemiological and behavioural correlates of drug-resistant tuberculosis in a Tertiary Care Centre, Delhi, India.
    Dzeyie KA; Basu S; Dikid T; Bhatnagar AK; Chauhan LS; Narain JP
    Indian J Tuberc; 2019 Jul; 66(3):331-336. PubMed ID: 31439176
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Socio-demographic Profile of MDR-TB and XDR-TB Patients Admitted in DR-TB Centre, North India.
    Giri OP; Giri VP; Nikhil N
    J Assoc Physicians India; 2019 Oct; 67(10):61-64. PubMed ID: 31571455
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genotyping and clinical characteristics of multidrug and extensively drug-resistant tuberculosis in a tertiary care tuberculosis hospital in China.
    Yuan X; Zhang T; Kawakami K; Zhu J; Zheng W; Li H; Deng G; Tu S; Liu W
    BMC Infect Dis; 2013 Jul; 13():315. PubMed ID: 23849244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drug resistance pattern and mutation pattern in pediatric tuberculosis: Study from north India.
    Khurana P; Saigal K; Ghosh A
    Indian J Tuberc; 2021 Oct; 68(4):481-484. PubMed ID: 34752317
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epidemiological trends and outcomes of extensively drug-resistant tuberculosis in Shandong, China.
    He XC; Tao NN; Liu Y; Zhang XX; Li HC
    BMC Infect Dis; 2017 Aug; 17(1):555. PubMed ID: 28793873
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cross-sectional study about knowledge and attitudes toward multidrug-resistant and extensively drug-resistant tuberculosis in a high-burden drug-resistant country.
    Javed H; Tahir Z; Hashmi HJ; Jamil N
    Int J Mycobacteriol; 2016 Jun; 5(2):128-34. PubMed ID: 27242222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. From multidrug- to extensively drug-resistant tuberculosis: upward trends as seen from a 15-year nationwide study.
    Stoffels K; Allix-Béguec C; Groenen G; Wanlin M; Berkvens D; Mathys V; Supply P; Fauville-Dufaux M
    PLoS One; 2013; 8(5):e63128. PubMed ID: 23671662
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.
    Sharma A; Hill A; Kurbatova E; van der Walt M; Kvasnovsky C; Tupasi TE; Caoili JC; Gler MT; Volchenkov GV; Kazennyy BY; Demikhova OV; Bayona J; Contreras C; Yagui M; Leimane V; Cho SN; Kim HJ; Kliiman K; Akksilp S; Jou R; Ershova J; Dalton T; Cegielski P;
    Lancet Infect Dis; 2017 Jul; 17(7):707-715. PubMed ID: 28499828
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment efficacy of drug-resistant tuberculosis in Bashkortostan, Russia: A retrospective cohort study.
    Yunusbaeva M; Borodina L; Alekseev P; Davydov R; Yunusbaev U; Sharipov R; Bilalov F; Yunusbayev B
    Int J Infect Dis; 2019 Apr; 81():203-209. PubMed ID: 30794942
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Drug susceptibility patterns of Mycobacterium tuberculosis and clinical outcomes of drug-resistant tuberculosis at Srinagarind Hospital, a tertiary care center in northeastern Thailand.
    Reechaipichitkul W; Tubtim S; Chaimanee P
    Southeast Asian J Trop Med Public Health; 2011 Sep; 42(5):1154-62. PubMed ID: 22299441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.